Literature DB >> 26967183

Treatment and Long-Term Risks for Patients With a Diagnosis of Ductal Carcinoma In Situ.

Brett Snodgrass1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26967183     DOI： 10.1001/jamaoncol.2015.4872

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.

Authors:  Diana R Withrow; Lindsay M Morton; Rochelle E Curtis; Sara J Schonfeld; Amy Berrington de González
Journal:  Breast Cancer Res Treat       Date:  2017-07-25       Impact factor: 4.872

2.  Ductal carcinoma in situ is presumably not a metastatic disease: a reply to "Commentary: Wherein the authors attempt to minimize the confusion generated by their study 'Breast cancer mortality after a diagnosis of ductal carcinoma in situ' by several commentators who disagree with them and a few who don't: a qualitative study".

Authors:  Brett T Snodgrass
Journal:  Curr Oncol       Date:  2018-04-30       Impact factor: 3.677
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.